Codexis, Inc. engineers enzymes for pharmaceutical and chemical production. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development. Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms. Codexis markets and sells enzymes, development services and screening tools, providing manufacturing processes for active pharmaceutical ingredients (APIs), and their precursor pharmaceutical intermediates.